April 13, 2015 | The international biomed fund OrbiMed is considering raising a second fund in Israel, according to a “Globes” report. OrbiMed reportedly hopes to raise between $200-250 million, though the group has not yet begun recruiting investors. In Israel, OrbiMed is headed by Senior Managing Director Dr. Nissim Darvish together with Anat Naschitz and Erez Chimovits, among others.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments